This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Dec 18;157(12):JC6-7.

doi: 10.7326/0003-4819-157-12-201212180-02007.

ACP Journal Club. Apixaban reduced stroke or systemic embolism more than warfarin in AF regardless of renal function

Melvyn M Jones¹

Affiliations

PMID: 23247956
DOI: 10.7326/0003-4819-157-12-201212180-02007

Comment

ACP Journal Club. Apixaban reduced stroke or systemic embolism more than warfarin in AF regardless of renal function

Melvyn M Jones. Ann Intern Med. 2012.

. 2012 Dec 18;157(12):JC6-7.

doi: 10.7326/0003-4819-157-12-201212180-02007.

Author

Melvyn M Jones¹

Affiliation

¹ University College London Medical School, London, England, UK.

PMID: 23247956
DOI: 10.7326/0003-4819-157-12-201212180-02007

No abstract available

PubMed Disclaimer

Comment on

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.
Hohnloser SH, Hijazi Z, Thomas L, Alexander JH, Amerena J, Hanna M, Keltai M, Lanas F, Lopes RD, Lopez-Sendon J, Granger CB, Wallentin L. Hohnloser SH, et al. Eur Heart J. 2012 Nov;33(22):2821-30. doi: 10.1093/eurheartj/ehs274. Epub 2012 Aug 29. Eur Heart J. 2012. PMID: 22933567 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon